Xantho Bio. presented in The 50th Annual Meeting of Taiwanese Dermatological Association
Xantho Bio. participated in the 50th Annual Meeting of the Taiwanese Dermatological Association (TDA), held on November 15-17, 2024, at the Taipei International Convention Center. This annual meeting brought together international experts, scholars, and doctors in dermatology, dermatological immunology, and dermatologic surgery, providing a platform for exchanging innovative development in dermatological technologies and clinical applications. The conference discussed advances in the treatment of skin-related diseases and research on underlying mechanisms.
Xantho Bio. presented an oral report titled "From Mangosteen to a New Botanical Drug: The Application of Botanical Extracts in Treating Atopic Dermatitis." The presentation highlighted the preclinical studies of GM-XANTHO in the treatment of atopic dermatitis and pressure ulcers. It also showcased the potential of Xantho Bio. in the development of botanical medicines for skin treatments.
In the annual meeting, the team from Xantho Bio. had the opportunity to engage in discussions with several international experts, scholars, and dermatologists. The team gained valuable insights into the application and development of dermatological drugs within the healthcare industry. This exchange of knowledge has allowed the team to better understand physicians' prescribing habits, patients' medication preferences, and the development progress of other drugs, ultimately contributing to the advancement of Xantho Bio’s own research and development process.
Disclaimer
This article and related information on this site contain forward-looking statements. The forward-looking information requires the Company to make numerous assumptions and is subject to inherent risks, uncertainties, and other factors that are beyond the control of the Company which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. The Company undertakes no obligation to timely inform, update, or revise the information on this site if circumstances should change.
